Related Experiment Video

Updated: Jun 23, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Trials in coronary heart disease and hypertension with special reference to the elderly

L Wilhelmsen1

  • 1Department of Medicine, Ostra Hospital, Göteborg, Sweden.

European Heart Journal
|February 1, 1988
PubMed

Insights

Older patients benefit from treatments, but careful monitoring of side effects is crucial. Balancing treatment benefits against risks is essential, especially for those with serious conditions like myocardial infarction.

Area of Science:

  • Geriatric Medicine
  • Clinical Trials
  • Cardiovascular Medicine

Background:

  • Age is a significant factor influencing the risk of complications such as death, myocardial infarction (MI), and stroke.
  • The relationship between various clinical endpoints and age is dynamic, with the stroke-to-MI ratio increasing with advancing age.
  • Older individuals may exhibit increased vulnerability to treatment side effects and altered responses to interventions.

Purpose of the Study:

  • To evaluate the efficacy and safety of medical interventions in older patient populations.
  • To analyze how age impacts the detection of treatment effects in clinical trials.
  • To assess the balance between therapeutic benefits and adverse events in elderly patients undergoing treatment for cardiovascular conditions.

Main Methods:

  • Review of clinical trials involving patients with hypertension and myocardial infarction.
  • Analysis of age-related changes in endpoint ratios (e.g., stroke vs. MI).
  • Assessment of metabolic side effects and quality-of-life measures in different age groups.

Main Results:

  • Treatment effects observed in older patients were comparable to those in younger patients for interventions in hypertension and myocardial infarction.
  • Metabolic side effects, including impaired glucose metabolism and elevated creatinine/uric acid levels, were notable in older adults.
  • The prognosis of the untreated condition significantly influences the acceptable level of treatment side effects, with more side effects being tolerable in post-MI patients.

Conclusions:

  • Interventions for conditions like hypertension and myocardial infarction demonstrate efficacy in older adults.
  • Metabolic side effects of treatments may pose greater risks in the elderly population.
  • A thorough risk-benefit assessment, considering the prognosis of the untreated disease, is critical for optimizing treatment strategies in aging patients.

More Related Videos

Standardized Rat Coronary Ring Preparation and Real-Time Recording of Dynamic Tension Changes Along Vessel Diameter07:53

Standardized Rat Coronary Ring Preparation and Real-Time Recording of Dynamic Tension Changes Along Vessel Diameter

Published on: June 16, 2022

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...